1.
|
Phase: Phase IV
Type: Supportive care, Treatment
Status: Approved-not yet active
Age: 35 to 90
Sponsor: Other
Protocol IDs: 047838, NCT00805701
|
|
2.
|
Phase: Phase IV
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS31, EudraCT number: 2008-008604-40, NCT00884273
|
|
3.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Adult
Sponsor: NCI
Protocol IDs: SWOG-9346, SWOG-9346, CAN-NCIC-PR8, CALGB-9594, ECOG-S9346, EORTC-30985, CAN-NCIC-JPR8, INT-0162, NCT00002651, PR8
|
|
4.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: LMU-ADEBAR, EU-20221, NCT00047099
|
|
5.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Under 80
Sponsor: Other
Protocol IDs: FRE-FNCLCC-GETUG-12/0203, EU-20238, NCT00055731
|
|
6.
|
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 to 49
Sponsor: NCI
Protocol IDs: SWOG-S0230, CALGB-40401, ECOG-S0230, NCT00068601, IBCSG-34-05, EUDRACT-2006-002600-33, EU-20632
|
|
7.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: FRE-FNCLCC-GETUG-15/0403, NCT00104715
|
|
8.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-0521, NCT00288080
|
|
9.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 2003-0819, NCT00388804
|
|
10.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: FRE-FNCLCC-GETUG-16/0504, EU-20668, EUDRACT-2005-005165, NCT00423475
|
|
11.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: CALGB-90203, NCT00430183
|
|
12.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: CRUK-OPTION, EUDRACT-2004-000133-11, CRUK-BR0402, ISRCTN84856516, EU-20680, NCT00427245
|
|
13.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 15 to 46
Sponsor: Other
Protocol IDs: 2005-0464, NCT00429403
|
|
14.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: OCOG-P1, NCT00439751
|
|
15.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: MRC-RADICALS-PR10, MRC-RADICALS-PR10, ISRCTN40814031, EUDRACT-2006-000205-34, EU-20767, PR13, NCT00541047
|
|
16.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D539BC00001, NCT00605267
|
|
17.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Not specified
Sponsor: NCI
Protocol IDs: CAN-NCIC-PR12, PR12, NCT00651326
|
|
18.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS28, 2008-004338-26 (EudraCT No), NCT00831233
|
|
19.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS30, 2008-005232-33 (EudraCT No), NCT00833248
|
|
20.
|
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: D8664L00012, NCT00888082
|
|
21.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: 4P-06-3, NCT00669162
|
|
22.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: MUSC-031218, 100822, MUSC-HR-11357, NCT00103376
|
|
23.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 05-8538-V 01, FHCRC-05026, NCT00298155
|
|
24.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: GEICAM/2006-03, NCT00432172
|
|
25.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-14954A, 7659, NCT00454571
|
